Caris Life Sciences (CAI) Total Liabilities (2024 - 2026)

Caris Life Sciences' Total Liabilities history runs 3 years deep, the most recent figure standing at $568.9 million for Q1 2026.

• On a quarterly basis, Total Liabilities changed N/A year-over-year to $568.9 million in Q1 2026; TTM through Mar 2026 was $568.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $548.4 million, down 11.69% from the prior year.
• Total Liabilities advanced to $568.9 million in Q1 2026 per CAI's latest filing, from $548.4 million in the prior quarter.
• Across five years, Total Liabilities topped out at $620.9 million in Q4 2024 and bottomed at $502.2 million in Q2 2025.
• The 3-year median for Total Liabilities is $548.4 million (2025), against an average of $549.3 million.
• Biggest YoY gain for Total Liabilities was 11.69% in 2025; the steepest drop was 11.69% in 2025.
• Year by year, Total Liabilities stood at $620.9 million in 2024, then fell by 11.69% to $548.4 million in 2025, then gained by 3.75% to $568.9 million in 2026.
• Per Business Quant, the three latest CAI Total Liabilities figures stand at $568.9 million (Q1 2026), $548.4 million (Q4 2025), and $506.2 million (Q3 2025).